134 related articles for article (PubMed ID: 13370600)
1. Role of the adrenal in response of rats to orinase.
DULIN WE; MORLEY EH; NEZAMIS JE
Proc Soc Exp Biol Med; 1956 Oct; 93(1):133-6. PubMed ID: 13370600
[No Abstract] [Full Text] [Related]
2. Studies on the mechanism of action of orinase (tolbutamide).
VAUGHAN M
Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412
[No Abstract] [Full Text] [Related]
3. Hypoglycemic action of orinase, effect on output of glucose by liver.
ANDERSON GE; PERFETTO AJ; TERMINE CM; MONACO RR
Proc Soc Exp Biol Med; 1956 Jun; 92(2):340-5. PubMed ID: 13350341
[No Abstract] [Full Text] [Related]
4. Effect of tolbutamide (orinase) on plasma non-esterified fatty acids.
BIERMAN EL; ROBERTS TN; DOLE VP
Proc Soc Exp Biol Med; 1957 Jul; 95(3):437-9. PubMed ID: 13453461
[No Abstract] [Full Text] [Related]
5. Antibacterial properties of orinase in infected mice.
LEWIS C
Proc Soc Exp Biol Med; 1957 Apr; 94(4):772-4. PubMed ID: 13431950
[No Abstract] [Full Text] [Related]
6. [New substances with effect on blood sugar].
ZAWACKI F; JUNG F
Klin Wochenschr; 1957 Apr; 35(7):363-4. PubMed ID: 13429840
[No Abstract] [Full Text] [Related]
7. Clinical use of tolbutamide (orinase) in office and home care of diabetics.
BRENEMAN JC
J Am Med Assoc; 1957 Jun; 164(6):627-33. PubMed ID: 13428534
[No Abstract] [Full Text] [Related]
8. Some effects of orinase in the rat.
LANG S; SHERRY S
Metabolism; 1956 Nov; 5(6 Part 2):733-8. PubMed ID: 13378040
[No Abstract] [Full Text] [Related]
9. Acute effects of orinase on peripheral glucose utilization.
GILBERTSEN AS; GOETZ FC; JOSEPHSON V
Metabolism; 1956 Nov; 5(6 Part 2):788-800. PubMed ID: 13378048
[No Abstract] [Full Text] [Related]
10. The site of action of the arylsulfonylureas in man.
FROESCH ER; RENOLD AE; THORN GW; WINEGRAD AI
Diabetes; 1957; 6(1):33; discussion, 43-5. PubMed ID: 13397418
[No Abstract] [Full Text] [Related]
11. Observations on the action of tolbutamide.
ANDERSON GE; MONACO RN; PERFETTO AJ; TERMINE CM
Diabetes; 1957; 6(1):34-40; discussion, 43-5. PubMed ID: 13397419
[No Abstract] [Full Text] [Related]
12. On the action of BZ-55 and D-860 in pancreatectomized dogs.
SCHAMBYE P
Diabetes; 1957; 6(2):146-50. PubMed ID: 13427619
[No Abstract] [Full Text] [Related]
13. Studies on the actions of oral hypoglycemic compounds.
COX RW; WILLIAMS RH
Diabetes; 1957; 6(3):270-3. PubMed ID: 13427634
[No Abstract] [Full Text] [Related]
14. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues.
BRITTON B; GRABOWSKI R; WICK AN
Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041
[No Abstract] [Full Text] [Related]
15. Some observations on the mode of action of orinase.
ARAI Y; ELRICK H; HLAD C; PRATT E; PURNELL R
Metabolism; 1956 Nov; 5(6 Part 2):778-87. PubMed ID: 13378047
[No Abstract] [Full Text] [Related]
16. Physiologic actions of orinase and their relationship to the types of diabetes in man.
KARK RM; MOORHOUSE JA
Metabolism; 1956 Nov; 5(6 Part 2):847-63. PubMed ID: 13378054
[No Abstract] [Full Text] [Related]
17. Action of the hypoglycemic sulfonyl compounds in hypophysectomized, adrenalectomized and depancreatized animals.
HOUSSAY BA; PENHOS JC
Metabolism; 1956 Nov; 5(6 Part 2):727-32. PubMed ID: 13378039
[No Abstract] [Full Text] [Related]
18. Metabolic effects of orinase in diabetes including two cases complicated by other endocrinopathies; preliminary report.
DIRAIMONDO VC; FORSHAM PH; MORTIMORE GE
Metabolism; 1956 Nov; 5(6 Part 2):840-6. PubMed ID: 13378053
[No Abstract] [Full Text] [Related]
19. The use of orinase in diabetes.
BEASER SB
Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062
[No Abstract] [Full Text] [Related]
20. Comparative effects of insulin and orinase on blood levels of pyruvate and alpha-ketoglutarate in normal subjects.
CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL
Metabolism; 1957 Jan; 6(1):63-9. PubMed ID: 13386969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
